ARCHIVES

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

This article is from The Cancer Letter archive.

Vol. 29 No. 10 | October 27, 2006

Download PDF Visit The Full Archive

Related Articles

ACD Asks Senate To Raise Budget Of CDC Cancer Programs

July 30, 1993

NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone

January 14, 1977

Federal Regs Prohibit RFP Budget Releases

February 21, 1975

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

Clinical Trials: Stories On Results Can Have Unintended Consequences

May 15, 1998

NIGMS Forms Bioinformatics, Computational Bio Center.

May 25, 2001